Bulk-sorted total plasmablasts from PBMCs and germinal centre B cells at 4 weeks after primary immunization from 3 vaccinees who had no prior history of infection with SARS-CoV-2.
Most patients with advanced non-small cell lung cancer (NSCLC) do not achieve a durable remission after treatment with immune checkpoint inhibitors. Here we report the clinical history of an exception
Chimeric antigen receptor (CAR)-modified T-cells have become established as an effective treatment of haematological cancers. In the context of relapsed and refractory childhood pre-B cell acute lymph
Purpose of the study. To determine the prognostic value of cellular immunity parameters in patients with coronary artery disease undergoing coronary artery bypass grafting under cardiopulmonary bypass
